- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有2家主力机构披露2025-06-30报告期持股数据，持仓量总计1.26亿股，占流通A股17.66%
- 波段诊断：
-
技术面诊股
诊断结果：5.7技术面打败了43%的股票
技术面评分前10的股票
近期的平均成本为1.00元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为1.00元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"1.00","date":1760518636,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2025.10.16","stock":"-1.96","trade":"0.19","ind":"0.10"},{"date":"2025.10.15","stock":"3.03","trade":"2.81","ind":"1.22"},{"date":"2025.10.14","stock":"-1.00","trade":"-1.22","ind":"-0.62"},{"date":"2025.10.13","stock":"-0.99","trade":"-0.84","ind":"-0.19"},{"date":"2025.10.10","stock":"1.00","trade":"-0.24","ind":"-0.94"},{"date":"2025.10.09","stock":"5.26","trade":"-0.39","ind":"1.32"},{"date":"2025.09.30","stock":"-5.00","trade":"0.72","ind":"0.52"},{"date":"2025.09.29","stock":"-4.76","trade":"-0.14","ind":"0.90"},{"date":"2025.09.26","stock":"5.00","trade":"-1.67","ind":"-0.65"},{"date":"2025.09.25","stock":"5.26","trade":"-0.91","ind":"-0.01"},{"date":"2025.09.24","stock":"5.56","trade":"1.94","ind":"0.83"},{"date":"2025.09.23","stock":"-1.10","trade":"-1.95","ind":"-0.18"},{"date":"2025.09.22","stock":"-1.09","trade":"-0.40","ind":"0.22"},{"date":"2025.09.19","stock":"-3.16","trade":"-1.50","ind":"-0.30"},{"date":"2025.09.18","stock":"2.15","trade":"-0.61","ind":"-1.15"},{"date":"2025.09.17","stock":"-1.06","trade":"-0.67","ind":"0.37"},{"date":"2025.09.16","stock":"-1.05","trade":"-0.09","ind":"0.04"},{"date":"2025.09.15","stock":"-5.00","trade":"-0.14","ind":"-0.26"},{"date":"2025.09.12","stock":"3.09","trade":"0.60","ind":"-0.12"},{"date":"2025.09.11","stock":"-2.02","trade":"0.29","ind":"1.65"},{"date":"2025.09.10","stock":"4.21","trade":"-0.63","ind":"0.13"}]
*ST苏吴,上证指数,化学制药指数
压力支撑
该股压力位为0.99元，支撑位为0.97元。
[{"text":"\u538b\u529b\u4f4d","value":"0.99","date":1760544000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"0.97","date":1760544000,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了10%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月16日 20:37
| 机构今日流向(万元) | -1313.72 | 机构5日流向(万元) | -5648.76 |
| 机构10日流向(万元) | -10281.09 | 机构20日流向(万元) | -21612.62 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少3205.54万股，其中基金数没有增加，主力净减仓76家，请投资者中长期谨慎为宜。
截止2025-06-30，共2家主力机构（一般法人2家），持仓量总计12554.67万股，占流通A股17.66%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：76家 ，原持有2907.05万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：76家 ，原持有2907.05万股
消息面诊股
诊断结果：5.5消息面打败了50%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- *ST苏吴：股价低于1元
2025-10-14 - *ST苏吴10月09日涨停分析
2025-10-09 - 涨停雷达：创新药+化学制药+ST板块+退市风险 *
2025-10-09 - *ST苏吴上演“地天板”
2025-10-09 - *ST苏吴：公司股票可能因股价低于1元而终止上市
2025-09-30 - 【兴·公告】关于上交所“*ST苏吴”重点监控证券交
2025-09-29 - *ST苏吴公告称公司股票存在多重退市风险
2025-09-29 - *ST苏吴：存在重大违法强制退市、财务类退市、面值
2025-09-26 - *ST苏吴09月26日涨停分析
2025-09-26 - 行业周报|化学制药指数跌-2.99%, 跑输上证指
2025-09-26
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2025-10-13 |
| 一般消息 | 募资投向 | 2025-09-17 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 一般消息 | 高管变动 | 工作调整原因 | 2025-08-21 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2025-07-24 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-07-15 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-07-14 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-06-27 |
| 一般消息 | 高管变动 | 调整委员会 | 2025-06-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-14 |
| 利空 | 上市变动 | 特别处理*ST | 2025-05-06 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-30 |
| 一般消息 | 高管变动 | 基于加快公司高级管理人员职业化进程... | 2025-04-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-21 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-01-21 |
| 一般消息 | 高管变动 | 因个人身体原因 | 2024-12-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-01 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-10-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：5.5行业面打败了70%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.10.16","price":"0.10","value":"0.19"},{"date":"2025.10.15","price":"1.22","value":"2.81"},{"date":"2025.10.14","price":"-0.62","value":"-1.22"},{"date":"2025.10.13","price":"-0.19","value":"-0.84"},{"date":"2025.10.10","price":"-0.94","value":"-0.24"},{"date":"2025.10.09","price":"1.32","value":"-0.39"},{"date":"2025.09.30","price":"0.52","value":"0.72"},{"date":"2025.09.29","price":"0.90","value":"-0.14"},{"date":"2025.09.26","price":"-0.65","value":"-1.67"},{"date":"2025.09.25","price":"-0.01","value":"-0.91"},{"date":"2025.09.24","price":"0.83","value":"1.94"},{"date":"2025.09.23","price":"-0.18","value":"-1.95"},{"date":"2025.09.22","price":"0.22","value":"-0.40"},{"date":"2025.09.19","price":"-0.30","value":"-1.50"},{"date":"2025.09.18","price":"-1.15","value":"-0.61"},{"date":"2025.09.17","price":"0.37","value":"-0.67"},{"date":"2025.09.16","price":"0.04","value":"-0.09"},{"date":"2025.09.15","price":"-0.26","value":"-0.14"},{"date":"2025.09.12","price":"-0.12","value":"0.60"},{"date":"2025.09.11","price":"1.65","value":"0.29"},{"date":"2025.09.10","price":"0.13","value":"-0.63"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 向日葵 | 133.77% | 19.05% | 5.8分 |
| 2 | 多瑞医药 | 31.61% | 19.78% | 6.1分 |
| 3 | 广生堂 | 16.03% | 34.16% | 6.1分 |
| 4 | 康芝药业 | 14.61% | 10.77% | 6.6分 |
| 5 | 宏源药业 | 13.78% | 17.34% | 4.8分 |
| 6 | 盟科药业 | 12.93% | -10.27% | 4.9分 |
| 8 | 昂利康 | 8.36% | 17.09% | 5.9分 |
| 10 | 莱美药业 | 6.19% | 12.68% | 6.4分 |
| 12 | 赛分科技 | 4.78% | 5.50% | 5.8分 |
| 14 | 信立泰 | 3.01% | -2.67% | 5.5分 |
| 16 | 常山药业 | 2.39% | -1.62% | 5.4分 |
| 18 | 兴齐眼药 | 1.49% | 6.36% | 6.3分 |
| 20 | 舒泰神 | 1.22% | 11.19% | 6.3分 |
| 22 | 百利天恒 | 1.10% | -5.38% | 5.2分 |
| 24 | 辰欣药业 | 0.76% | 5.70% | 5.8分 |
| 26 | 苑东生物 | 0.57% | 1.54% | 5.7分 |
| 28 | 恩华药业 | 0.27% | -6.62% | 4.7分 |
| 30 | 罗欣药业 | 0.18% | 12.86% | 6.2分 |
| 32 | 海正药业 | -0.19% | -0.48% | 5.7分 |
| 34 | 天新药业 | -0.51% | 1.45% | 5.9分 |
| 36 | 力生制药 | -0.54% | 2.58% | 6.3分 |
| 38 | 前沿生物 | -0.68% | 2.23% | 5.1分 |
| 40 | 富士莱 | -0.81% | 2.17% | 5.3分 |
| 42 | 立方制药 | -1.23% | 4.20% | 6.1分 |
| 44 | 海南海药 | -1.67% | 7.69% | 6.6分 |
| 46 | 北大医药 | -1.74% | 1.64% | 6.5分 |
| 48 | 华北制药 | -1.81% | 0.51% | 6.1分 |
| 50 | 宣泰医药 | -1.93% | -0.56% | 5.5分 |
| 52 | 润都股份 | -2.18% | 2.20% | 5.5分 |
| 54 | 华东医药 | -2.46% | -1.99% | 5.7分 |
| 56 | 花园生物 | -2.51% | -2.10% | 5.2分 |
| 58 | 津药药业 | -2.59% | 1.72% | 5.7分 |
| 60 | 民生健康 | -2.73% | 1.02% | 5.5分 |
| 62 | 联环药业 | -2.82% | 13.17% | 6.2分 |
| 64 | 小方制药 | -3.16% | 0.18% | 5.5分 |
| 66 | 东亚药业 | -3.32% | -0.10% | 5.2分 |
| 68 | 华特达因 | -3.54% | 1.95% | 5.5分 |
| 70 | 西点药业 | -3.68% | 2.29% | 5.8分 |
| 72 | 哈三联 | -3.93% | 4.43% | 5.4分 |
| 74 | 奥锐特 | -4.01% | -1.81% | 5.9分 |
| 76 | - | -4.18% | 1.57% | 分 |
| 78 | *ST三圣 | -4.29% | 1.30% | 4.3分 |
| 80 | 本立科技 | -4.38% | 0.70% | 5.6分 |
| 82 | 汉商集团 | -4.47% | 3.55% | 5.9分 |
| 84 | 广济药业 | -4.64% | 2.08% | 5.9分 |
| 86 | 浙江医药 | -4.76% | -0.41% | 5.6分 |
| 88 | 溢多利 | -5.03% | 0.30% | 4.8分 |
| 90 | - | -5.23% | 6.95% | 分 |
| 92 | 誉衡药业 | -5.28% | 3.19% | 6.3分 |
| 94 | 丽珠集团 | -5.69% | -2.63% | 5.3分 |
| 96 | 神奇制药 | -6.08% | 3.77% | 5.8分 |
| 98 | 京新药业 | -6.17% | -9.22% | 4.8分 |
| 100 | 易明医药 | -6.36% | -1.37% | 4.3分 |
| 102 | 人福医药 | -6.49% | -1.59% | 5.3分 |
| 104 | - | -6.89% | 3.82% | 分 |
| 106 | 莎普爱思 | -7.04% | 1.83% | 5.2分 |
| 108 | 诚意药业 | -7.28% | 2.14% | 5.4分 |
| 110 | 复星医药 | -7.49% | -2.31% | 5.3分 |
| 112 | 奥翔药业 | -7.52% | 0.00% | 5.4分 |
| 114 | 键凯科技 | -7.63% | -6.18% | 5.0分 |
| 116 | 东诚药业 | -7.87% | -2.07% | 5.4分 |
| 118 | 同和药业 | -7.88% | -2.55% | 5.2分 |
| 120 | 尔康制药 | -7.96% | 1.46% | 5.5分 |
| 122 | 司太立 | -8.33% | -3.85% | 5.4分 |
| 124 | - | -8.44% | 2.34% | 分 |
| 126 | 美诺华 | -8.82% | 0.50% | 4.7分 |
| 128 | *ST赛隆 | -9.73% | -4.23% | 4.7分 |
| 130 | - | -9.86% | 2.53% | 分 |
| 132 | 千红制药 | -9.98% | -0.99% | 4.9分 |
| 134 | 翰宇药业 | -10.17% | -0.41% | 5.3分 |
| 136 | 泽璟制药 | -10.24% | -3.67% | 5.2分 |
| 138 | ST诺泰 | -10.51% | -10.07% | 4.6分 |
| 140 | 海翔药业 | -10.78% | -2.39% | 5.2分 |
| 142 | 一品红 | -12.37% | -4.39% | 4.8分 |
| 144 | 能特科技 | -12.73% | -1.54% | 5.8分 |
| 146 | - | -15.58% | -0.75% | 分 |
| 148 | 悦康药业 | -16.65% | 0.27% | 5.0分 |
| 150 | 贝达药业 | -18.23% | -14.17% | 4.7分 |
| 152 | 华海药业 | -19.25% | -5.38% | 4.8分 |
| 154 | 新诺威 | -21.91% | -1.18% | 4.8分 |
| 156 | 南新制药 | -35.08% | -10.33% | 4.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 122/218 ， 38/218。
[{"date":"2025-06-30","value":"-2.47","vol":"1.40"},{"date":"2025-03-31","value":"-3.93","vol":"-0.17"},{"date":"2024-12-31","value":"3.95","vol":"19.77"},{"date":"2024-09-30","value":"2.55","vol":"4.61"},{"date":"2024-06-30","value":"1.39","vol":"3.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.47 | -3.93 | 3.95 | 2.55 | 1.39 |
| 行业(%) | 1.40 | -0.17 | 19.77 | 4.61 | 3.55 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"64.62","vol":"49.76"},{"date":"2025-03-31","value":"63.67","vol":"49.23"},{"date":"2024-12-31","value":"48.33","vol":"51.11"},{"date":"2024-09-30","value":"34.54","vol":"50.51"},{"date":"2024-06-30","value":"29.15","vol":"50.85"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
64.62 | 63.67 | 48.33 | 34.54 | 29.15 |
| 行业(%) | 49.76 | 49.23 | 51.11 | 50.51 | 50.85 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 135/218 ， 139/218。
[{"date":"2025-06-30","value":"-27.08","vol":"79.06"},{"date":"2025-03-31","value":"-25.44","vol":"-0.84"},{"date":"2024-12-31","value":"-28.64","vol":"17.88"},{"date":"2024-09-30","value":"9.58","vol":"45.69"},{"date":"2024-06-30","value":"9.62","vol":"710.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-27.08 | -25.44 | -28.64 | 9.58 | 9.62 |
| 行业(%) | 79.06 | -0.84 | 17.88 | 45.69 | 710.38 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-281.63","vol":"56.66"},{"date":"2025-03-31","value":"-1489.93","vol":"-21.21"},{"date":"2024-12-31","value":"197.97","vol":"-21.14"},{"date":"2024-09-30","value":"311.54","vol":"-32.33"},{"date":"2024-06-30","value":"-10.75","vol":"8.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-281.63 | -1489.93 | 197.97 | 311.54 | -10.75 |
| 行业(%) | 56.66 | -21.21 | -21.14 | -32.33 | 8.14 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 87/218 ， 16/218。
[{"date":"2025-06-30","value":"0.16","vol":"0.21"},{"date":"2025-03-31","value":"0.08","vol":"0.10"},{"date":"2024-12-31","value":"0.39","vol":"0.43"},{"date":"2024-09-30","value":"0.39","vol":"0.33"},{"date":"2024-06-30","value":"0.29","vol":"0.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.08 | 0.39 | 0.39 | 0.29 |
| 行业(次) | 0.21 | 0.10 | 0.43 | 0.33 | 0.23 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.62","vol":"1.32"},{"date":"2025-03-31","value":"1.22","vol":"0.67"},{"date":"2024-12-31","value":"8.21","vol":"3.24"},{"date":"2024-09-30","value":"11.46","vol":"2.18"},{"date":"2024-06-30","value":"8.31","vol":"1.51"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.62 | 1.22 | 8.21 | 11.46 | 8.31 |
| 行业(次) | 1.32 | 0.67 | 3.24 | 2.18 | 1.51 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 82/218 ， 72/218。
[{"date":"2025-06-30","value":"12.28","vol":"2.81"},{"date":"2025-03-31","value":"-291.28","vol":"-28.76"},{"date":"2024-12-31","value":"","vol":"-371.46"},{"date":"2024-09-30","value":"-68.62","vol":"-9.87"},{"date":"2024-06-30","value":"29.02","vol":"-253.98"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 12.28 | -291.28 | - | -68.62 | 29.02 |
| 行业 | 2.81 | -28.76 | -371.46 | -9.87 | -253.98 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.79","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.68","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.01","vol":"2.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.79 | - | 0.68 | - | 1.01 |
| 行业 | 1.73 | 0.00 | 1.99 | 0.00 | 2.19 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 32/218 ， 34/218。
[{"date":"2025-06-30","value":"1.51","vol":"3.66"},{"date":"2025-03-31","value":"1.48","vol":"3.59"},{"date":"2024-12-31","value":"1.53","vol":"3.32"},{"date":"2024-09-30","value":"1.50","vol":"3.66"},{"date":"2024-06-30","value":"1.46","vol":"3.59"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.51 | 1.48 | 1.53 | 1.50 | 1.46 |
| 行业 | 3.66 | 3.59 | 3.32 | 3.66 | 3.59 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.29","vol":"2.88"},{"date":"2025-03-31","value":"1.26","vol":"2.81"},{"date":"2024-12-31","value":"1.46","vol":"2.63"},{"date":"2024-09-30","value":"1.44","vol":"2.92"},{"date":"2024-06-30","value":"1.39","vol":"2.88"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.29 | 1.26 | 1.46 | 1.44 | 1.39 |
| 行业 | 2.88 | 2.81 | 2.63 | 2.92 | 2.88 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 12/218 ， 27/218。
[{"date":"2025-06-30","value":"52.21","vol":"33.92"},{"date":"2025-03-31","value":"54.16","vol":"34.04"},{"date":"2024-12-31","value":"52.48","vol":"34.34"},{"date":"2024-09-30","value":"54.98","vol":"33.02"},{"date":"2024-06-30","value":"55.48","vol":"33.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
52.21 | 54.16 | 52.48 | 54.98 | 55.48 |
| 行业(%) | 33.92 | 34.04 | 34.34 | 33.02 | 33.19 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.14","vol":"0.89"},{"date":"2025-03-31","value":"1.23","vol":"1.46"},{"date":"2024-12-31","value":"1.14","vol":"0.84"},{"date":"2024-09-30","value":"1.26","vol":"0.73"},{"date":"2024-06-30","value":"1.29","vol":"0.71"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.14 | 1.23 | 1.14 | 1.26 | 1.29 |
| 行业(%) | 0.89 | 1.46 | 0.84 | 0.73 | 0.71 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.23","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.76","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.72","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.70","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]